Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk

Public Health Genomics

Volumn 17, Issue 1, 2014, Pages 48-60

  Anderson, A E ^a   Flores, K G ^e   Boonyasiriwat, W ^a,i   Gammon, A ^a   Kohlmann, W ^a   Birmingham, W C ^d   Schwartz, M D ^g,h   Samadder, J ^a,b   Boucher, K ^a,c   Kinney, A Y ^a,b,e,f  

^a UNIVERSITY OF UTAH   (United States)

^b Departments of Internal Medicine   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Behavior change; Cancer risk; Colorectal cancer; Direct to consumer; First degree relatives; Genomic; SNP

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; DEMOGRAPHY; FAMILY HISTORY; FEMALE; GENETIC SCREENING; GENOME; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PSYCHOLOGY; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; GENETIC PREDISPOSITION; GENETICS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UTILIZATION REVIEW;

ADULT; AGED; COLORECTAL NEOPLASMS; DECISION MAKING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84899722162     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000356567     Document Type: Article

References (49)

1. Jasperson KW, Tuohy TM, Neklason DW, Burt RW: Hereditary and familial colon cancer. Gastroenterology 2010; 138: 2044-2058.
2. National Comprehensive Cancer Network: Clinical practice guidelines in oncology: colorectal cancer screening. Version 22013. http://www.nccn.org.
3. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group: Recommendations from the EGAPP working group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from lynch syndrome in relatives. Genet Med 2009; 11: 35-41.
4. Ait Ouakrim D, Lockett T, Boussioutas A, Hopper JL, Jenkins MA: Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review of meta-analysis. Fam Cancer 2013; 12: 459-472.
5. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA: Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010; 138: 877-885.
6. American Cancer Society: American cancer society recommendations for colorectal cancer early detection. http://www.cancerorg/ cancer/colonandrectumcancer/moreinformation/ colonandrectumcancerearlydetection/ colorectal-cancer-early-detection-acsrecommendations.
7. Siegert S, Hampe J, Schafmayer C, von Schönfels W, Egberts JH, Försti A, Chen B, Lascorz J, Hemminki K, Franke A, Nothnagel M, Nöthlings U, Krawczak M: Genome-wide investigation of gene-environment interactions in colorectal cancer. Hum Genet 2013; 132: 219-231.
8. Fugger L, McVean G, Bell JI: Genomewide association studies and common disease-realizing clinical utility. N Engl J Med 2012; 367: 2370-2371.
9. Ramsey S, Blough D, McDermott C, Clarke L, Bennett R, Burke W, Newcomb P: Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study. Public Health Genomics 2010; 13: 1-12.
10. Dvoskin R, Kaufman D: Tables of direct-toconsumer genetic testing companies and conditions tested-August 2011. Washington, DC, Genetics and Public Policy Center, 2011. http://www.dnapolicy.org/pub.reports.php (accessed August 24, 2013).
11. 23andMe: 2013. https://www.23andme.com/ (accessed January, 5 2013).
12. Accu-metrics/Viaguard: http://www.accumetrics. com/cancer-scan.Php (accessed August 24, 2013).
13. Herper M, Langreth R: Will you get cancer? Forbes 2007; 179: 52-68.
14. Wright CF, Gregory-Jones S: Size of the direct-to-consumer genomic testing market. Genetics 2010; 12: 594.
15. Saukko P: State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation. Proc Nutr Soc 2013; 72: 53-60.
16. Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD: Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics 2011; 14: 178-189.
17. Leventhal KG, Tuong W, Peshkin BN, Salehizadeh Y, Fishman MB, Eggly S, FitzGerald K, Schwartz MD, Graves KD: 'Is it really worth it to get tested?': primary care patients' impressions of predictive SNP testing for colon cancer. J Genet Couns 2013; 22: 138-151.
18. Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B: A survey of UK public interest in internet-based personal genome testing. PloS One 2010; 5:e13473.
19. McBride CM, Wade CH, Kaphingst KA: Consumers' views of direct-to-consumer genetic information. Ann Rev Genomics Hum Genet 2010; 11: 427-446.
20. Leventhal H, Brissette I, Leventhal EA: The common-sense model of self-regulation of health and illness; in Cameron LD, Leventhal H (eds): The Self-Regulation of Health and Illness Behaviour. London and New York, Routledge, 2003, pp 42-65.
21. Marteau TM, Weinman J: Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 2006; 62: 1360-1368.
22. Pengchit W, Walters ST, Simmons RG, Kohlmann W, Burt RW, Schwartz MD, Kinney AY: Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. J Health Psychol 2011; 16: 1187-1197.
23. Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY: Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multistate colonoscopy intervention trial. Trials 2013; 14: 116.
24. O'Neill SC, Bowling JM, Brewer NT, Lipkus IM, Skinner CS, Strigo TS, Rimer BK: Intentions to maintain adherence to mammography. J Womens Health (Larchmt) 2008; 17: 1133-1141.
25. Witte K, Meyer G, Martell D: Effective health risk messages: a step-by-step guide. California, Sage Publications, Inc., 2001.
26. Costa PT, McCrae RR: Normal personality assessment in clinical practice: the neo personality inventory. Psychol Assess 1992; 4: 5-13.
27. McCaul KD, Goetz PW: National Cancer Institute: Worry. http://dccps.nci.nih.gov/BRP/ constructs/worry/index.html (accessed December 5, 2013).
28. Hay JL, Primavera L, Gurmankin Levy A, et al: Development and validation of a scale assessing novel cancer-related risk perceptions. Abstracts 27th Annu Meet Society for Behavioral Medicine. San Francisco, March, 2006.
29. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67: 1063-1078.
30. Rural Health Research Center University of Washington: Rural-urban commuting areas (RUCAS). Seattle, University of Washington, 2007.
31. US Department of Health and Human Services: Physical activity guidelines for Americans, 2008. http://www.Health.Gov/paguidelines/ factsheetprof.Aspx (accessed January 10, 2013).
32. Centers for Disease Control and Prevention: About BMI for adults. http://www.Cdc.Gov/ healthyweight/assessing/bmi/adult-bmi/index. Html (accessed January 10, 2013).
33. Burton AM, Peterson SK, Marani SK, Vernon SW, Amos CI, Frazier ML, Lynch PM, Gritz ER: Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control 2010; 21: 513-521.
34. Emmons KM, McBride CM, Puleo E, Pollak KI, Marcus BH, Napolitano M, Clipp E, Onken J, Farraye FA, Fletcher R: Prevalence and predictors of multiple behavioral risk factors for colon cancer. Prev Med 2005; 40: 527-534.
35. McBride CM, Bryan AD, Bray MS, Swan GE, Green ED: Health behavior change: can genomics improve behavioral adherence? Am J Public Health 2012; 102: 401-405.
36. Bloss CS, Schork NJ, Topol EJ: Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524-534.
37. Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, Attwood S, Hollands GJ: Effects of communicating DNAbased disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 2010;CD007275.
38. Schully SD, Benedicto CB, Khoury MJ: How can we stimulate translational research in cancer genomics beyond bench to bedside? Genet Med 2012; 14: 169-170.
39. Bloss CS, Madlensky L, Schork NJ, Topol EJ: Genomic information as a behavioral health intervention: can it work? Per Med 2011; 8: 659-667.
40. So JY: A further extension of the extended parallel process model (E-EPPM): implications of cognitive appraisal theory of emotion and dispositional coping style. Health Commun 2013; 28: 72-83.
41. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kääriäinen H: Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001; 93: 608-611.
42. Cameron LD, Reeve J: Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychol Health 2006; 21: 211-230.
43. Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, Distante A, Di Paola L, Paradiso A: Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population. Ann Oncol 2004; 15(suppl 1):I48-I54.
44. Weinrich S, Royal C, Pettaway CA, Dunston G, Faison-Smith L, Priest JH, Roberson-Smith P, Frost J, Jenkins J, Brooks KA, Powell I: Interest in genetic prostate cancer susceptibility testing among african American men. Cancer Nurs 2002; 25: 28-34.
45. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG: Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth 2009; 9: 3-10.
46. Powell KP, Christianson CA, Cogswell WA, Dave G, Verma A, Eubanks S, Henrich VC: Education needs of primary care physicians regarding direct-to-consumer genetic testing. J Genet Couns 2012; 21: 469-478.
47. Gollust SE, Gordon ES, Zayac C, Griffin G, Christman MF, Pyeritz RE, Wawak L, Bernhardt BA: Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 2012; 15: 22-30.
48. Birmingham WC, Agarwal N, Kohlmann W, Aspinwall LG, Wang M, Bishoff J, Dechet C, Kinney AY: Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study. BMC Health Serv Res 2013; 13: 279.
49. Haga SB, Carrig MM, O'Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS, Cho A: Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J Gen Intern Med 2011; 26: 834-840.